Atypical Frontotemporal Dementia Associated With <i>SQSTM1</i> Gene Mutation: A Clinicopathological Case

A 78-year-old man presented with a six-year history of progressive memory decline, initially manifesting as recent memory impairment and mild anomia, which gradually evolved into motor clumsiness, gait disturbances, language difficulties, behavioral changes, and late-onset parkinsonism. He had been diagnosed with Paget disease of bone (PDB) at the age of 45. Brain MRI revealed asymmetric left anterior temporal atrophy, while [<sup>18</sup>F]-Fluorodeoxyglucose (FDG) PET demonstrated frontotemporal hypometabolism, predominantly on the left side, with marked involvement of both temporal poles and greater hypometabolism in the left temporal pole. A negative amyloid PET scan supported a diagnosis of frontotemporal dementia (FTD). Genetic analysis identified an SQSTM1 gene mutation (c.1210A>G; p.(Met404Val)). Post-mortem examination confirmed frontotemporal lobar degeneration with atypical TDP-43 protein distribution, alongside tau and Lewy body pathology. This case exemplifies an atypical presentation of FTD, characterized by amnestic onset with subsequent language and behavioral involvement, thereby broadening the recognized clinical spectrum of SQSTM1-associated FTD. The coexistence of parkinsonism and PDB, alongside mixed proteinopathies, underscores the phenotypic heterogeneity of SQSTM1 mutations. These findings emphasize the importance of considering prominent memory impairment, semantic deficits, and parkinsonism as potential manifestations in this genetic form and highlight the need for comprehensive clinical, genetic, and neuropathological evaluation to improve diagnosis and inform therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Neuropathology
Published
2025-10-12
DOI
https://doi.org/10.1111/neup.70029
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Atypical Frontotemporal Dementia Associated With SQSTM1 Gene Mutation: A Clinicopathological Case

Ana Patiño‐García, María Victoria Zelaya, Mario Riverol, Genoveva Montoya‐Murillo et al.
Neuropathology
Amyotrophic Lateral Sclerosis Research
article

Atypical Frontotemporal Dementia Associated With SQSTM1 Gene Mutation: A Clinicopathological Case

Ana Patiño‐García, María Victoria Zelaya, Mario Riverol, Genoveva Montoya‐Murillo, Javier Arbizu, Victoria Pueyo, Christian Espinoza‐Vinces, Rafael Villino‐Rodríguez, Ainhoa Atorrasagasti‐Villar
article en

Abstract

A 78-year-old man presented with a six-year history of progressive memory decline, initially manifesting as recent memory impairment and mild anomia, which gradually evolved into motor clumsiness, gait disturbances, language difficulties, behavioral changes, and late-onset parkinsonism. He had been diagnosed with Paget disease of bone (PDB) at the age of 45. Brain MRI revealed asymmetric left anterior temporal atrophy, while [<sup>18</sup>F]-Fluorodeoxyglucose (FDG) PET demonstrated frontotemporal hypometabolism, predominantly on the left side, with marked involvement of both temporal poles and greater hypometabolism in the left temporal pole. A negative amyloid PET scan supported a diagnosis of frontotemporal dementia (FTD). Genetic analysis identified an SQSTM1 gene mutation (c.1210A>G; p.(Met404Val)). Post-mortem examination confirmed frontotemporal lobar degeneration with atypical TDP-43 protein distribution, alongside tau and Lewy body pathology. This case exemplifies an atypical presentation of FTD, characterized by amnestic onset with subsequent language and behavioral involvement, thereby broadening the recognized clinical spectrum of SQSTM1-associated FTD. The coexistence of parkinsonism and PDB, alongside mixed proteinopathies, underscores the phenotypic heterogeneity of SQSTM1 mutations. These findings emphasize the importance of considering prominent memory impairment, semantic deficits, and parkinsonism as potential manifestations in this genetic form and highlight the need for comprehensive clinical, genetic, and neuropathological evaluation to improve diagnosis and inform therapeutic strategies.

NeuropathologyVol. 45(6)
Navarre Institute of Health Research (ES), Navarrabiomed (ES), Clinica Universidad de Navarra (ES), Universidad de Navarra (ES)
Openalex Percentile: Top 59%
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.